PMA device
Navistar Deflectable Tip Diagnostic/Ablation Catheter
Biosense Webster, Inc. · Catheter, Electrode Recording, Or Probe, Electrode Recording (DRF, Class II) · First FDA decision Sep 26, 2001, newest Nov 13, 2002Atrial fibrillationVentricular arrhythmia and sudden cardiac arrest
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
3
Naming "Navistar Deflectable Tip"
MAUDE reports
0
Brand "Navistar Deflectable Tip", since 2015
PubMed studies
0
Mentioning "Navistar Deflectable Tip"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Navistar Deflectable Tip Diagnostic/Ablation Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- NAVISTAR DEFLECTABLE TIP DIAGNOSTIC/ABLATION CATHETERPMA supplement
P950005-S015 · Decided Nov 13, 2002 · 210 days after receipt · Normal 180 Day Track
Device type: CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING (DRF) · Cardiology
- NAVISTAR DEFLECTABLE TIP DIAGNOSTIC/ABLATION CATHETERPMA supplement
P990025-S005 · Decided Nov 13, 2002 · 210 days after receipt · Normal 180 Day Track
Device type: CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING (DRF) · Cardiology
- NAVISTAR DEFLECTABLE TIP DIAGNOSTIC/ABLATION CATHETERPMA supplement
P990025-S002 · Decided Sep 26, 2001 · 289 days after receipt · Normal 180 Day Track
Device type: CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING (DRF) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Stereotaxic Depth Electrode ImplantationNational determinationOn the books160.5Updated Apr 20, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Navistar Deflectable Tip", any status and sponsor, newest update first.
Biosense Webster, Inc.Public (JNJ)
NCT00721149 · 10 participants · Start Sep 2008 · Primary completion Dec 2009
Device: Radiofrequency Ablation · For: Heart Diseases; Arrhythmia; Atrial Fibrillation
- NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial FibrillationPivotal-lookingCompleted
Biosense Webster, Inc.Public (JNJ)
NCT00116428 · 167 participants · Start Oct 1, 2004 · Primary completion Oct 1, 2007
Device: NAVISTAR® THERMOCOOL® Catheter · For: Heart Diseases; Arrhythmia; Atrial Fibrillation
Sites: Greenbrae, California; Orlando, Florida; Maywood, Illinois · 17 sites in all
David B. De LurgioAcademic, hospital or other
NCT02009982 · 3 participants · Start Dec 2013 · Primary completion Dec 2015
Device: Biosense Webster Navistar ThermoCool Diagnostic/Ablation Deflectable Tip Catheter · For: Neurocardiogenic Syncope; Vasovagal Syncope
Sites: Atlanta, Georgia; Chapel Hill, North Carolina
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Navistar Deflectable Tip", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DRF
6,595 reports: 3,079 malfunction, 3,259 injury, 233 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0369-2010 · Started Oct 2, 2008 · Posted by FDA Nov 19, 2009
Reason given: Biosense Webster initiated the recall because of the potential concern with one of the Printed Circuit Board (PCB) components used in the NaviStar RMT Catheters, which may cause the ablation catheter icon to shift on the map viewer when RF energy is being applied. Therefore the user, attempting a linear ablation in...
Cause as FDA categorized it: Process control · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Published research
The most relevant PubMed records for "Navistar Deflectable Tip"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code DRF.
- NavistarBiosense Webster, Inc. · PMA 2022
- Navi-Star Diagnostic/Ablation Deflectable Tip CatheterBiosense Webster, Inc. · PMA 2017
- Stockert 70 Radiofrequency Ablation GeneratorBiosense Webster, Inc. · PMA 2005
- Celsius Diagnostic/Ablation Deflectable Tip CatheterBiosense Webster, Inc. · PMA 2001
- Celsius/Celsius II Diagnostic/Ablation Deflectable Tip Catheters and Temperature CablesBiosense Webster, Inc. · PMA 2001
- nMARQ Catheter Interference CableBiosense Webster, Inc. · PMA 2024
- Biosense Webster CablesBiosense Webster, Inc. · PMA 2021
- Celsius Rmt Diagnostic/Ablation Deflectable Tip Catheters, Model D-1249-02-SBiosense Webster, Inc. · PMA 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.